HASUMI Immuno Clinic: Seven Decades of Hasumi Vaccine (HITV) Cancer Therapy
Medical Supporter — Information Notice
This article is a summary of international medical information and is not medical advice; it cannot replace the diagnosis or treatment plan of your attending physician. The medical technologies, drug information and clinical data presented here are compiled from public literature and official statements of major Japanese medical institutions; the applicability and outcome of any therapy vary with each patient and must be assessed individually by a qualified physician.
Located in Kioicho, Tokyo, HASUMI Immuno Clinic is a significant milestone in the history of global cancer vaccine research and development. Since Dr. Kiichiro Hasumi developed the first generation "Hasumi Vaccine" in 1948, the clinic has consistently focused on stimulating the body's self-healing power to combat stubborn cancer cells.
The Scientific Logic of Hasumi Vaccine (HITV)
The core of HITV (Hasumi Immuno-Therapeutic Vaccine) lies in "personalized autologous vaccines."
- Antigen Extraction: Antigens are extracted from the patient's tumor tissue or specific markers.
- Cell Education: The patient's dendritic cells are cultured in vitro and "educated" with the extracted antigens, giving them the ability to precisely identify cancer cells.
- Combined Attack: Combining subcutaneous injections with local lesion injections triggers a powerful T-cell response while clearing micro-metastases.
Why Do Patients Worldwide Trust HASUMI?
- Rich Clinical Track Record: With over 70 years of R&D history and more than 200,000 nurturing care cases, the clinic has a vast database supporting its nurturing care protocols.
- Extremely Low Side Effects: Since autologous immune components are used, the nurturing care process is gentle, allowing most patients to maintain their normal quality of life without affecting social or professional activities.
- Significant Improvement in Survival Rates: Multiple long-term follow-ups show that patients receiving HITV adjuvant therapy see an average increase of 15-20% in their 5-year survival rate.
Medical and Service Environment
The clinic is situated in the beautiful environment of Kioicho, near Akasaka, providing a highly private and tranquil medical space. The staff is extremely welcoming to overseas patients, maintaining a deep partnership with Medical Supporter's medical consultants to accompany you through the entire process—from blood sample logistics and vaccine production to administration in Japan.
[Medical Supporter Reminder] Medical Supporter was formerly certified as a medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).
Considering medical care in Japan? Need information and support?
We help you organize the information needed for medical travel to Japan, liaise with Japanese medical institutions, and arrange a second-opinion consultation.The first consultation is free; an advisor will help you clarify the next steps.